Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nu Skin Enterprises reports $2.23B revenue for 2022, focuses on innovation and social commerce

Nu Skin Enterprises navigated challenges in 2022, focusing on innovation and social commerce to drive revenue growth. The company aims to overcome challenges in 2023 and achieve Nu Vision 2025 goals through strategic initiatives. Nu Skin's emphasis on enhancing the iO experience and optimizing expenses positions it for sustainable value to investors.

Nu Skin Enterprises meets Q1 expectations, eyes growth in Asia

Nu Skin's Q1 performance in line with expectations, with notable success in key markets like South Korea and Mainland China.
Challenges persist in certain regions due to macroeconomic factors, necessitating strategic adjustments for sustained growth.
Opportunities lie in expanding TRMe program, leveraging digital initiatives, and driving operational improvements for long-term value creation.

Nu Skin reports robust Q2 earnings, eyes growth through acquisitions

Nu Skin Enterprises delivered strong Q2 results driven by Mainland China growth, with revenue of $500.3 million and EPS of $0.54. The company faces challenges in other markets due to macro-related pressures.
Strategic acquisitions of BeautyBio and LifeDNA aim to enhance Nu Skin's core business through personalization and technology. The company's focus on innovation and market trends presents growth opportunities.
With a clear strategic direction, Nu Skin is poised to navigate challenges, capitalize on opportunities, and drive continued growth in the beauty and wellness industry.

Nu Skin reports Q3 revenue of $499M, adjusts 2023 guidance

Nu Skin adjusts 2023 guidance, expecting revenue of $1.92B to $1.96B and EPS of negative $0.10 to $0.05. The company is streamlining expenses and maximizing cash flow.

Nu Skin surpasses Q4 revenue targets, eyes growth opportunities

Nu Skin Enterprises delivered strong Q4 results, exceeding revenue guidance and showcasing a focus on innovation and strategic growth initiatives.
Despite challenges in certain regions, the company demonstrated resilience and stability in key markets, laying the groundwork for future expansion and market penetration.
By rebalancing dividends for growth investments and prioritizing reinvestment in the business, Nu Skin is poised to capitalize on opportunities for market diversification and sustainable growth.
With a clear roadmap for 2024, including product launches, market entries, and capital reallocation strategies, Nu Skin is well-positioned to drive performance and enhance shareholder value.

Nu Skin Enterprises reports robust Q1 earnings, eyes global expansion

Nu Skin Enterprises showcased resilience in revenue and earnings, driven by strong performance in core and new business segments.
While facing challenges from macroeconomic factors, the company is strategically focused on innovation, cost efficiency, and market expansion.
Opportunities lie in product diversification, market entries, and sustainability efforts, positioning Nu Skin for future growth and market leadership.

Nu Skin surpasses Q2 revenue targets, eyes growth amid challenges

Nu Skin Enterprises delivered strong Q2 performance, exceeding revenue guidance and showcasing financial discipline. Despite challenges in China and FX pressures, the company remains focused on innovation and growth. Strategic investments in new products, markets, and brand awareness position Nu Skin for future success. Revised guidance reflects adaptability to market conditions and commitment to long-term vision.

Nu Skin Enterprises meets Q3 guidance, eyes India expansion

Nu Skin's Q3 performance reflects a balanced approach to addressing challenges and leveraging strengths.
Strategic initiatives to drive growth, optimize operations, and expand into new markets are key focus areas.
Despite market pressures, Nu Skin's focus on innovation and efficiency bodes well for future growth.
Overall, Nu Skin's financials and strategic direction indicate a resilient and forward-thinking company.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin Enterprises, Inc. (NYSE:NUS ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Scott Pond – Vice President-Investor Relations Ryan Napierski – President and Chief Executive Officer James Thomas – Chief Financial Officer Conference Call Participants Tristen Chau – Stifel Doug Lane – Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by.

Nu Skin Enterprises, Inc. (NUS) Q3 2023 Earnings Call Transcript

PROVO, Utah , Nov. 1, 2023 /PRNewswire/ -- Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter 2023 results. Executive Summary Q3 2023 vs.

Nu Skin Enterprises Reports Third Quarter 2023 Financial Results

Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

Nu Skin's (NUS) third-quarter 2023 earnings will likely reflect macroeconomic challenges, including a slowdown in consumer spending. Nevertheless, strength in the Nu Vision 2025 strategy bodes well.

Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings

Citizens Financial Group

Bancolombia

Ecopetrol

Euronav

Himax Tech

HSBC Holdings

Hercules Capital

ICL-Israel Chemicals

Dorian LPG

NatWest Group plc 

Blue Owl Capital Corp

Petroleo Brasileiro

Provident Financial Services

RMR Group

Sibanye Stillwater

Sociedad Quimica Y Minera De Chile

TORM

“Value ranking, looks at the price of a stock relative to intrinsic firm value. Graham Value Stocks match the criteria Benjamin Graham followed. “—YCharts Value Screener. 68 November Value large caps and Graham formula-derived results reflect established value-stock detection-criteria. Of those, 58 met the dogcatcher-Notorious-ideal of dividends from $1K invested exceeding their single-share-stock-prices. Representing eight-of-eleven Morningstar Sectors, all 58 ideal value-picks pay regular-dividends. Broker-target-top-ten net-gains ranged 38.29%-81.03%, topped by SBSW & SQM, as-of 10/23/23.

68 Ben Graham November Value Stocks: 58 Notorious Buys

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth

Nu Skin (NUS) is on track with its Nu Vision 2025 strategy. However, the company is operating amid macroeconomic hurdles.

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

PROVO, Utah , Oct. 3, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release third quarter 2023 results after the market closes on Wednesday, Nov. 1. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m.

Nu Skin Enterprises to Announce Third Quarter 2023 Financial Results

Nu Skin Enterprises had been impacted by COVID-19 initially and tough macro-environment recently, leading to a decline in sales and lowered guidance for 2023. The company reported resilient Q2 earnings with sustained gross margins and in line EPS supported by strong growth in China. Despite the challenges, the valuation appears attractive at just 8.7x Fwd PE and a forward dividend yield of 6.7%.

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Nu Skin's (NUS) margins have been contracting year over year for a while now. The company is also battling unfavorable currency headwinds.

Nu Skin (NUS) Appears Dull on High Cost & Currency Headwinds

Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consumer spending and customer acquisition.

Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world's No. 1 brand for beauty device systems for six consecutive years by Euromonitor International Ltd., which publishes the world's most comprehensive market research on the skincare industry. Nu Skin is the world's best-selling beauty device system brand based on Euromonitor custom research and methodology conducted April to June of 2023.* “We're continuing our indust.

Nu Skin Ranked the World's #1 Brand for Beauty Device Systems for Six Consecutive Years

Nu Skin (NUS) reports sequential improvements in Q2 results, driven by the Mainland China and Rhyz segments. However, macro-economic factors pose challenges in the key markets.

Nu Skin (NUS) Lowers 2023 Guidance Despite Q2 Earnings Beat

NU Skin Enterprises, Inc. (NYSE:NUS ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President, CEO & Director Connie Tang - EVP & Chief Global Growth & Customer Experience Officer James Thomas - Interim CFO Conference Call Participants Chasen Bender - Citi Blake Anderson - Jefferies Christopher Armes - Stifel Linda Bolton-Weiser - D.A. Davidson Operator Good day, ladies and gentlemen.

NU Skin Enterprises, Inc. (NUS) Q2 2023 Earnings Call Transcript

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.77 per share a year ago.

Nu Skin Enterprises (NUS) Surpasses Q2 Earnings Estimates

PROVO, Utah , Aug. 1, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2023 results in line with expectations. Executive Summary Q2 2023 vs.

Nu Skin Enterprises Reports Second Quarter 2023 Financial Results

PROVO, Utah , Aug. 1, 2023 /PRNewswire/ -- Rhyz Inc., a subsidiary of Nu Skin Enterprises Inc. (NYSE: NUS), today announced the acquisition of BeautyBio, a clean and clinically proven skincare and beauty device brand. Rhyz adds this omnichannel beauty brand to its existing synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

Rhyz Inc. Acquires Skincare and Beauty Device Company BeautyBio

PROVO, Utah , July 27, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of James D. Thomas as executive vice president and chief financial officer.

Nu Skin Enterprises Appoints James D. Thomas as Chief Financial Officer

Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.

Nu Skin (NUS) Gears Up for Q2 Earnings: What's in Store?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?

PROVO, Utah, July 10, 2023 (GLOBE NEWSWIRE) -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second quarter 2023 results after the market closes on Tuesday, Aug. 1. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.

Nu Skin Enterprises to Announce Second Quarter 2023 Financial Results

Demand is currently weak due to lower consumer purchasing power as a consequence of inflation. Strong inflationary pressures are also negatively impacting profit margins, which remain depressed. The company has recently launched three new products, including the Beauty Focus Collagen+ skin care supplement, the ageLOC Meta nutritional supplement, and ageLOC LumiSpa iO.

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

The company continues its commitment to help children worldwide with hospital kits and hygiene products, as well as a donation to Primary Children's Hospital in Utah County from its nonprofit foundation The company continues its commitment to help children worldwide with hospital kits and hygiene products, as well as a donation to Primary Children's Hospital in Utah County from its nonprofit foundation

Nu Skin Celebrates 20th Annual Force for Good Day with Global Day of Service

Nu Skin's (NUS) first-quarter 2023 results reflect difficult year-over-year comparisons and macroeconomic hurdles. However, a focus on the Nu Vision 2025 strategy has been working well.

Nu Skin (NUS) Q1 Earnings & Revenues Top Estimates, Dip Y/Y

NU Skin Enterprises, Inc. (NYSE:NUS ) Q1 2023 Earnings Conference Call May 3, 2023 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President, CEO & Director Connie Tang - EVP & Chief Global Growth & Customer Experience Officer James Thomas - Interim CFO Conference Call Participants Chasen Bender - Citi Operator Good day and thank you for standing by. Welcome to the Quarter One Nu Skin Enterprises Earnings Conference Call.

News for Nu Skin Enterprises Stock (NUS)